Paris - Delayed Quote EUR

Euroapi S.A. (EAPI.PA)

4.3300

+0.1740

(+4.19%)

At close: September 13 at 5:35 PM GMT+2

EUROAPI - Availability of 2024 Half-Year Financial Report

Paris, 05 August, 2024 – EUROAPI posted today its 2024 condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2024. This document is available for consultation and downloading on EUROAPI’s website: https://www.euroapi.com/en/investors/regulatory-information/financial-reports. This report includes notably the 2024 half-year management report, the consolidated financial statements on 30 June 2024, and the Statutory Auditors’ review report on the half-yearly financi

GlobeNewswire last month

EAPIF
H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap

Press ReleaseParis, 30th July 2024 Net Sales down 9.6% year-on-year – Core EBITDA margin at 10.6%Accelerated commercial momentum with clients other than Sanofi, with Net Sales up 2.9%, excluding the Brindisi site, where production was temporarily suspendedEnhanced effectiveness across the entire organization, with sizeable improvements in industrial efficiencies€10 million Free Cash Flow before financing, driven by strengthened financial disciplineFY 2024 guidance confirmed " Our H1 actions set

GlobeNewswire last month

EAPIF
EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1

Press Release Agreement with Sanofi on a 200 M€ investment through a Perpetual Subordinated Hybrid Bond, upon the completion of the ongoing discussions to amend and extend the current Revolving Credit Facility75 to 80 M€ annual run-rate incremental Core EBITDA targeted by the end of 2027, driven by the end of higher value API and CDMO offering, a streamlined industrial footprint, and significant cost reductions Brindisi site expected to progressively resume shipments and production during Q3 202

GlobeNewswire 2 months ago

EAPIF
EUROAPI and Priothera enter into CDMO collaboration to advance oncology project

Press Release EUROAPI and Priothera, a biotechnology company specializing in the treatment of hematological malignancies and the improvement of CAR-T cell therapies, have signed a 5-year CDMO agreementEUROAPI will develop and industrialize the manufacturing process of innovative complex molecule for blood cancers Paris – June 18, 2024 – EUROAPI announces today the implementation of a 5-year development and manufacturing agreement with Priothera, a biotechnology company specializing in molecules

GlobeNewswire 2 months ago

EAPIF
Market update : FOCUS-27 transformation project financing

Press release Paris – June 6, 2024 – EUROAPI informs that it has decided to be assisted by a mandataire ad hoc in its discussions initiated in February 2024 regarding the mid-term and long-term financing of its FOCUS-27 strategic transformation project. The mandat ad hoc is an amicable procedure launched at the company's initiative and conducted within a confidential and legally secured framework. EUROAPI has appointed such an independent third party proactively to accelerate the outcome of the

GlobeNewswire 3 months ago

EAPIF
EUROAPI reaches major Health IPCEI milestone with official notification from European Commission

Press Release Paris – June 6, 2024 – EUROAPI has received official notification from the European Commission that the Company has been selected as one of the 13 companies eligible to share up to EUR 1 billion in total public funding under the Important Project of Common European Interest (IPCEI) dedicated to the pharmaceutical sector, “IPCEI Med4Cure”. This IPCEI had been jointly notified by six Member States of the European Union, i.e. France, Belgium, Hungary, Italy, Slovakia and Spain as a me

GlobeNewswire 3 months ago

EAPIF
EUROAPI strengthens its presence in animal health with a €130-150 million supply contract

Press Release A 5-year manufacturing contract to support the FOCUS-27 project sales trajectoryThis contract highlights EUROAPI’s know-how and the reliability of its premium Contract Manufacturing Organization services to customers Paris – May 23, 2024 – EUROAPI announces today that it has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company. As part of this collaboration, EUROAPI will supply its client with a key veterinary product. The total con

GlobeNewswire 3 months ago

EAPIF
Combined General Meeting of May 22, 2024

Press Release Approval of all resolutions put forward by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2023Ratification of the co-option of Géraldine Leveau as a Director Paris – May 22, 2024 – The Combined General Shareholders’ Meeting of EUROAPI was held on May 22, 2024 in Paris, under the chairwomanship of Viviane Monges, and was attended by all directors. All resolutions put forth to a vote were adopted by the shareholders. The Genera

GlobeNewswire 3 months ago

EAPIF
Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer

Press Release Paris – May 13, 2024 - Evelyne Nguyen has been appointed EUROAPI’s Chief Financial Officer, effective May 14, 2024, and will be a member of the Executive Committee. She is taking over from Antoine Delcour, who is leaving the company to pursue new endeavors. Antoine will remain within the company until the end of June to ensure a smooth transition. “The entire company and the Board of Directors join me in expressing our sincere gratitude to Antoine for his outstanding dedication to

GlobeNewswire 3 months ago

EAPIF
Combined General Meeting of May 22, 2024 - Availability of preparatory documents

Press Release Paris – April 30, 2024 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 22, 2024 at 10:00 a.m. (CET) at the Centre de Conférences Verso, 52 rue de la Victoire 75009 Paris.The notice of meeting was published at the French official legal announcement publication (BALO) on Friday April 12, 2024 (bulletin n°45) and the convening notice (avis de convocation) was published in the Actu-juridique.fr, a French journal of legal notice, o

GlobeNewswire 4 months ago

EAPIF
EUROAPI streamlines its Executive Committee to improve focus and efficiency

Press Release Paris – April 9, 2024 – EUROAPI today announces a streamlining of its Executive Committee around operational functions in order to improve focus and efficiency. This organizational adjustment is part of the transformation of EUROAPI into an innovative API supplier and CDMO with a unique, high-quality and customized product offering. As part of this move, Guillaume Rosso has been appointed as Chief Commercial Officer, succeeding Laurent Alexandre who has decided to pursue other oppo

GlobeNewswire 5 months ago

EAPIF
Availability of the 2023 Universal Registration Document, including the Annual Financial Report

Press Release Paris – April 5, 2024 – EUROAPI announces the publication of its 2023 Universal Registration Document, filed with the French Autorité des marchés financiers (AMF) on April 5, 2024. The 2023 Universal Registration Document includes in particular: The annual financial report;The Board of Directors’ corporate governance report;The information about social, environmental, and societal responsibility (including the extra-financial performance declaration);The statutory auditors reports,

GlobeNewswire 5 months ago

EAPIF
2023 Universal Registration Document

Press Release Paris – March 28, 2024 – EUROAPI today announces that its 2023 Universal Registration Document will be filed with the French Financial Markets Authority (AMF) on April 5, 2024. Financial calendar May 22, 2024: Annual Shareholder General MeetingQ2 2024: Further information on FOCUS-27 projectJuly 31, 2024 (before market opening): H1 2024 Results About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the wo

GlobeNewswire 5 months ago

EAPIF
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy

Press Release Paris – March 14th, 2024 – EUROAPI today announces that its Italian subsidiary, EUROAPI Italy S.R.L., is suspending the production of all APIs1 in Brindisi. Following an internal audit, quality control deficiencies due to potential local misconduct have been identified and are being further investigated. Production will remain suspended until further notice. The relevant health authorities have been informed. The company has initiated a forensic audit and will inform its customers.

GlobeNewswire 5 months ago

EAPIF
Full-year 2023 results

Ludwig de Mot appointed Chief Executive Officer Strategic Review outcome: launch of the FOCUS-27 project to improve competitiveness and unlock sustainable & profitable growth Full-Year 2023 results: resilience in a challenging business environment 1,013.2 million in Net Sales, up 3.8%1€93.1 million Core EBITDA, with a 9.2% Core EBITDA margin, down from 12.3% in 2022 due to unfavorable fixed cost absorption and input cost inflation€226.4 million impairment on Tangible Assets€(189.7) million Net i

GlobeNewswire 6 months ago

EAPIF
EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO)

PARIS & BASEL, Switzerland, January 25, 2024--Regulatory News: EUROAPI (Paris:EAPI) announced today that it has initiated a pivotal collaboration with SpiroChem, a leading Contract Research Organization (CRO) with best-in-class status in the field of early Chemical Process R&D (route scouting). SpiroChem is headquartered in Basel, Switzerland.

Business Wire 7 months ago

EAPIF
EUROAPI Strengthens its Executive Committee with the Appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer

PARIS, January 04, 2024--Regulatory News: EUROAPI (Paris:EAPI) today announced the appointment of Ludwig de Mot as Executive Vice President (EVP) - Chief Transformation Officer.

Business Wire 8 months ago

EAPIF
EUROAPI Appoints New Executive Committee Members

PARIS, November 28, 2023--Regulatory News: EUROAPI (Paris:EAPI) today announced the appointment of David Seignolle as Chief Operating Officer, succeeding Eric Berger, and Marion Santin as Chief Legal, Compliance, and IP Officer, both joining the company’s Executive Committee.

Business Wire 9 months ago

EAPIF
CDMO: EUROAPI Completes Acquisition of Biano

PARIS, November 21, 2023--Regulatory News: EUROAPI (Paris:EAPI) today announced the completion of the acquisition of BianoGMP ("Biano"), strengthening its CDMO expertise in the high-growth oligonucleotide market.

Business Wire 9 months ago

EAPIF
EUROAPI: Information Relating to the Financial Terms of the Departure of the Chief Executive Officer and the Appointment of the Chairman of the Board as Interim Chief Executive Officer

PARIS, October 30, 2023--Regulatory News: EUROAPI (Paris:EAPI):

Business Wire 10 months ago

EAPIF

Performance Overview

Return	EAPI.PA	CAC 40
YTD	-24.43%	-1.03%
1-Year	-66.01%	+2.93%
3-Year	-65.36%	+19.28%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Euroapi S.A. (EAPI.PA)

EUROAPI - Availability of 2024 Half-Year Financial Report

H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap

EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1

EUROAPI and Priothera enter into CDMO collaboration to advance oncology project

Market update : FOCUS-27 transformation project financing

EUROAPI reaches major Health IPCEI milestone with official notification from European Commission

EUROAPI strengthens its presence in animal health with a €130-150 million supply contract

Combined General Meeting of May 22, 2024

Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer

Combined General Meeting of May 22, 2024 - Availability of preparatory documents

EUROAPI streamlines its Executive Committee to improve focus and efficiency

Availability of the 2023 Universal Registration Document, including the Annual Financial Report

2023 Universal Registration Document

Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy

Full-year 2023 results

EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO)

EUROAPI Strengthens its Executive Committee with the Appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer

EUROAPI Appoints New Executive Committee Members

CDMO: EUROAPI Completes Acquisition of Biano

EUROAPI: Information Relating to the Financial Terms of the Departure of the Chief Executive Officer and the Appointment of the Chairman of the Board as Interim Chief Executive Officer

Performance Overview